Shiva Mohtashami, MD
Family Practice · Morgan Hill
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 34
- 9 carriers
- Office
- 1
Offices
1 location
Hospitals listed: 059765 · El Camino Health · Santa Clara Valley Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
34 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mohtashami’s office at (408) 659-7300 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
34 of 34 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A132424 · Current
Licensed to practise in California · since 2014 · expires 2027-12-31 · American University of the Caribbean School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$102,160
Medicare paid this office $102,160 for 190 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 150 | $39,085 | $113 |
| Long return visit (40+ min) | 80 | $23,044 | $168 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 66 | $10,396 | $158 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 12 | $4,950 | $127 |
| Short return visit (20+ min) | 62 | $4,916 | $76 |
See all 12 services
| Return visit (30+ min) | 150 | $39,085 | $113 |
| Long return visit (40+ min) | 80 | $23,044 | $168 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 66 | $10,396 | $158 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 12 | $4,950 | $127 |
| Short return visit (20+ min) | 62 | $4,916 | $76 |
| New patient visit (60+ min) | 22 | $4,085 | $186 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 87 | $2,284 | $15 |
| New patient visit (45+ min) | 16 | $1,762 | $110 |
| Influenza vaccine, inactivated | 18 | $1,473 | $82 |
| Administration of influenza virus vaccine | 20 | $781 | $39 |
| Hemoglobin a1c level | 11 | $200 | $10 |
| Urinalysis, manual test | 12 | $41 | $3 |
Who their Medicare patients are
190 Original Medicare patients in 2024. Average age 75 · Women 66% · Also on Medicaid 8% · Health risk score 1.14. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Coronary heart disease 28% · Diabetes 27% · Chronic kidney disease 21% · Atrial fibrillation 19% · Heart failure 17% · Depression 15% · Stroke 13% · Cancer 12% · Dementia 12% · COPD 9%.
The office billed $365,800, Medicare allowed $132,270 and paid $102,160; for 1,037 services of 34 kinds; $1,545 of it was for drugs given in the office and $100,615 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 190 | 1,037 | 75 | 1.14 | $365,800 | $102,160 |
| 2023 | 175 | 667 | 74 | 0.98 | $248,225 | $73,318 |
| 2022 | 196 | 652 | 75 | 1.10 | $202,581 | $72,960 |
| 2021 | 149 | 432 | 74 | 1.24 | $75,898 | $41,879 |
| 2020 | 99 | 299 | 71 | 1.35 | $41,790 | $26,018 |
| 2019 | 96 | 236 | 72 | 1.27 | $35,807 | $19,268 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 125 | $38,179 | $115 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 65 | $10,053 | $155 |
| Short return visit (20+ min) | 67 | $6,919 | $80 |
| New patient visit (45+ min) | 43 | $5,224 | $121 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $2,273 | $120 |
| Administration of influenza virus vaccine | 12 | $448 | $37 |
2022: 7 services
| Return visit (30+ min) | 137 | $35,920 | $118 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 36 | $5,820 | $162 |
| Long return visit (40+ min) | 23 | $5,341 | $172 |
| New patient visit (45+ min) | 31 | $4,434 | $143 |
| Telephone medical discussion with physician, 21-30 minutes | 33 | $4,212 | $96 |
| Short return visit (20+ min) | 39 | $3,305 | $79 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $1,101 | $73 |
2021: 8 services
| Return visit (30+ min) | 62 | $14,260 | $120 |
| Telephone medical discussion with physician, 21-30 minutes | 49 | $8,863 | $109 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 26 | $4,110 | $158 |
| Telephone medical discussion with physician, 11-20 minutes | 37 | $3,460 | $80 |
| New patient visit (45+ min) | 13 | $1,678 | $129 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 50 mcg/0.25ml dosage, booster dose | 27 | $1,215 | $45 |
| Short return visit (20+ min) | 13 | $860 | $66 |
| Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 50 mcg/0.25ml dosage, for intramuscular use | 26 | $0 | $0 |
2020: 6 services
| Telephone medical discussion with physician, 21-30 minutes | 41 | $7,074 | $96 |
| Return visit (30+ min) | 41 | $5,346 | $80 |
| Telephone medical discussion with physician, 11-20 minutes | 45 | $4,526 | $68 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 19 | $3,589 | $189 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,768 | $136 |
| Short return visit (20+ min) | 18 | $987 | $52 |
2019: 3 services
| Return visit (30+ min) | 69 | $12,107 | $88 |
| Short return visit (20+ min) | 42 | $2,723 | $53 |
| New patient visit (45+ min) | 12 | $1,407 | $117 |
Medicaid work
$13,610 in 2022
Medicaid paid $13,610 for 137 billed services this clinician did in 2022, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 90 | $13,610 |
| Short return visit (20+ min) | 34 | $0 |
| Return visit (30+ min) | 13 | $0 |
| 2022 | 137 | 3 | 25 | $13,610 |
| 2021 | 479 | 3 | 35 | $45,918 |
| 2020 | 873 | 4 | 67 | $76,176 |
| 2019 | 833 | 2 | 86 | $107,134 |
| 2018 | 366 | 1 | 63 | $55,190 |
See the largest Medicaid services in earlier years
2021
| Clinic visit/encounter, all-inclusive | 294 | $45,696 |
| Return visit (30+ min) | 114 | $222 |
| Short return visit (20+ min) | 71 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 493 | $75,820 |
| Blood test, lipids (cholesterol and triglycerides) | 12 | $228 |
| Short return visit (20+ min) | 233 | $128 |
| Return visit (30+ min) | 135 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 714 | $107,134 |
| Short return visit (20+ min) | 119 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 366 | $55,190 |
Drugs they prescribed that Part D paid
$88,885
Pharmacies billed $88,885 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,206 generic and fewer than 11 brand-name prescriptions · $88,885 in drug cost · 106 antibiotic prescriptions to 67 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 34 | $27,995 | $823 |
| Januvia | 15 | $14,101 | $940 |
| Memantine | 18 | $1,971 | $109 |
| Rosuvastatin | 37 | $1,600 | $43 |
| Levothyroxine | 103 | $984 | $10 |
See all 35 drugs
| Jardiance | 34 | $27,995 | $823 |
| Januvia | 15 | $14,101 | $940 |
| Memantine | 18 | $1,971 | $109 |
| Rosuvastatin | 37 | $1,600 | $43 |
| Levothyroxine | 103 | $984 | $10 |
| Albuterol Sulfate Hfa | 29 | $699 | $24 |
| Atorvastatin | 94 | $528 | $6 |
| Amlodipine Besylate | 58 | $397 | $7 |
| Metoprolol | 30 | $368 | $12 |
| Duloxetine | 14 | $324 | $23 |
| Nitrofurantoin Mono-Macro | 23 | $316 | $14 |
| Metformin | 32 | $296 | $9 |
| Simvastatin | 46 | $288 | $6 |
| Bupropion Xl | 17 | $285 | $17 |
| Montelukast | 22 | $285 | $13 |
| Lisinopril | 52 | $270 | $5 |
| Sertraline | 39 | $259 | $7 |
| Ezetimibe | 13 | $257 | $20 |
| Omeprazole | 16 | $245 | $15 |
| Losartan | 39 | $240 | $6 |
| Fluticasone Propionate | 21 | $226 | $11 |
| Amoxicillin-Clavulanate Potass | 23 | $167 | $7 |
| Benazepril | 14 | $156 | $11 |
| Donepezil | 17 | $145 | $9 |
| Gabapentin | 11 | $126 | $11 |
| Glipizide | 16 | $121 | $8 |
| Fluoxetine | 11 | $121 | $11 |
| Olmesartan Medoxomil | 11 | $118 | $11 |
| Hydrochlorothiazide | 39 | $103 | $3 |
| Azithromycin | 25 | $70 | $3 |
| Carvedilol | 13 | $65 | $5 |
| Prednisone | 14 | $59 | $4 |
| Alendronate | 19 | $53 | $3 |
| Triamcinolone Acetonide | 13 | $41 | $3 |
| Trazodone | 11 | $20 | $2 |
Year by year
| 2024 | 1,396 | 204 | None | None | $88,885 |
| 2023 | 1,249 | 211 | None | 12% | $77,731 |
| 2022 | 1,221 | 201 | None | 12% | $83,042 |
| 2021 | 815 | 124 | None | None | $60,262 |
| 2020 | 766 | 113 | None | None | $63,487 |
| 2019 | 771 | 115 | None | None | $29,202 |
| 2018 | 362 | 101 | None | 16% | $18,101 |
| 2017 | 672 | 62 | 0% (0) | None | $15,601 |
| 2016 | 556 | 65 | 0% (0) | None | $13,253 |
| 2015 | 629 | 68 | None | 17% | $29,272 |
| 2014 | 265 | 36 | None | 20% | $17,542 |
| 2013 | 187 | 28 | None | None | $10,690 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 32 drugs
| Januvia | 18 | $19,235 | $1,069 |
| Atorvastatin | 87 | $1,658 | $19 |
| Rosuvastatin | 34 | $1,019 | $30 |
| Levothyroxine | 77 | $981 | $13 |
| Omeprazole | 48 | $808 | $17 |
| Albuterol Sulfate Hfa | 26 | $606 | $23 |
| Lisinopril | 46 | $564 | $12 |
| Metformin | 40 | $529 | $13 |
| Amlodipine Besylate | 44 | $500 | $11 |
| Bupropion Hcl Sr | 13 | $443 | $34 |
| Fluticasone Propionate | 30 | $426 | $14 |
| Losartan | 29 | $409 | $14 |
| Gabapentin | 13 | $381 | $29 |
| Sertraline | 28 | $330 | $12 |
| Simvastatin | 28 | $324 | $12 |
| Metoprolol | 19 | $239 | $13 |
| Nitrofurantoin Mono-Macro | 12 | $232 | $19 |
| Tamsulosin | 14 | $223 | $16 |
| Montelukast | 27 | $221 | $8 |
| Alendronate | 12 | $203 | $17 |
| Lovastatin | 14 | $202 | $14 |
| Trazodone | 20 | $189 | $9 |
| Lisinopril-Hydrochlorothiazide | 12 | $126 | $10 |
| Azithromycin | 19 | $122 | $6 |
| Paxlovid (Eua) | 13 | $118 | $9 |
| Triamcinolone Acetonide | 14 | $115 | $8 |
| Amoxicillin-Clavulanate Potass | 19 | $110 | $6 |
| Benazepril | 14 | $106 | $8 |
| Famotidine | 11 | $85 | $8 |
| Cephalexin | 11 | $60 | $5 |
| Prednisone | 15 | $51 | $3 |
| Hydrochlorothiazide | 20 | $48 | $2 |
2022: 32 drugs
| Januvia | 31 | $27,238 | $879 |
| Eliquis | 12 | $12,443 | $1,037 |
| Xarelto | 12 | $6,494 | $541 |
| Atorvastatin | 102 | $1,520 | $15 |
| Albuterol Sulfate Hfa | 26 | $1,090 | $42 |
| Duloxetine | 13 | $1,033 | $79 |
| Levothyroxine | 57 | $994 | $17 |
| Lisinopril | 69 | $786 | $11 |
| Metformin | 64 | $713 | $11 |
| Rosuvastatin | 21 | $633 | $30 |
| Omeprazole | 44 | $560 | $13 |
| Amlodipine Besylate | 40 | $396 | $10 |
| Losartan | 45 | $393 | $9 |
| Fluticasone Propionate | 14 | $383 | $27 |
| Metoprolol | 18 | $355 | $20 |
| Simvastatin | 33 | $305 | $9 |
| Tamsulosin | 12 | $251 | $21 |
| Diltiazem 24hr Er | 12 | $209 | $17 |
| Carvedilol | 12 | $201 | $17 |
| Trazodone | 25 | $199 | $8 |
| Benazepril | 11 | $192 | $17 |
| Gabapentin | 20 | $189 | $9 |
| Hydrochlorothiazide | 37 | $147 | $4 |
| Atenolol | 11 | $131 | $12 |
| Sertraline | 22 | $126 | $6 |
| Paxlovid (Eua) | 11 | $106 | $10 |
| Cephalexin | 13 | $97 | $7 |
| Citalopram Hbr | 12 | $95 | $8 |
| Azithromycin | 13 | $75 | $6 |
| Furosemide | 13 | $71 | $5 |
| Triamcinolone Acetonide | 16 | $66 | $4 |
| Ciprofloxacin | 16 | $59 | $4 |
2021: 18 drugs
| Januvia | 27 | $22,840 | $846 |
| Xarelto | 12 | $6,214 | $518 |
| Atorvastatin | 86 | $1,171 | $14 |
| Levothyroxine | 67 | $1,088 | $16 |
| Rosuvastatin | 22 | $756 | $34 |
| Omeprazole | 29 | $453 | $16 |
| Amlodipine Besylate | 36 | $386 | $11 |
| Losartan | 38 | $334 | $9 |
| Lisinopril | 59 | $319 | $5 |
| Memantine | 12 | $287 | $24 |
| Metformin | 35 | $216 | $6 |
| Diltiazem 24hr Er | 11 | $192 | $17 |
| Citalopram Hbr | 21 | $180 | $9 |
| Simvastatin | 25 | $107 | $4 |
| Gabapentin | 15 | $72 | $5 |
| Metoprolol | 16 | $68 | $4 |
| Hydrochlorothiazide | 13 | $53 | $4 |
| Glipizide | 12 | $52 | $4 |
2020: 19 drugs
| Januvia | 32 | $19,888 | $621 |
| Atorvastatin | 97 | $966 | $10 |
| Levothyroxine | 42 | $690 | $16 |
| Omeprazole | 40 | $438 | $11 |
| Digoxin | 12 | $432 | $36 |
| Lisinopril | 55 | $235 | $4 |
| Amlodipine Besylate | 32 | $227 | $7 |
| Metformin | 40 | $218 | $5 |
| Losartan | 20 | $196 | $10 |
| Spironolactone | 16 | $194 | $12 |
| Lovastatin | 12 | $184 | $15 |
| Nitrofurantoin Mono-Macro | 13 | $175 | $13 |
| Simvastatin | 16 | $114 | $7 |
| Furosemide | 19 | $102 | $5 |
| Metoprolol | 18 | $89 | $5 |
| Hydrochlorothiazide | 16 | $84 | $5 |
| Ciprofloxacin | 16 | $66 | $4 |
| Glipizide | 12 | $63 | $5 |
| Sertraline | 12 | $40 | $3 |
2019: 19 drugs
| Atorvastatin | 85 | $949 | $11 |
| Ventolin Hfa | 11 | $756 | $69 |
| Levothyroxine | 43 | $628 | $15 |
| Metformin | 48 | $350 | $7 |
| Metoprolol | 26 | $347 | $13 |
| Lisinopril | 66 | $345 | $5 |
| Hydrochlorothiazide | 38 | $272 | $7 |
| Amlodipine Besylate | 29 | $219 | $8 |
| Omeprazole | 16 | $204 | $13 |
| Fluticasone Propionate | 16 | $190 | $12 |
| Amoxicillin-Clavulanate Potass | 15 | $182 | $12 |
| Carvedilol | 15 | $156 | $10 |
| Glimepiride | 18 | $134 | $7 |
| Simvastatin | 20 | $132 | $7 |
| Clonazepam | 12 | $81 | $7 |
| Sertraline | 12 | $81 | $7 |
| Triamcinolone Acetonide | 13 | $80 | $6 |
| Furosemide | 14 | $78 | $6 |
| Glipizide | 13 | $58 | $4 |
2018: 9 drugs
| Levothyroxine | 23 | $312 | $14 |
| Amoxicillin-Clavulanate Potass | 11 | $152 | $14 |
| Calcitriol | 11 | $151 | $14 |
| Fluticasone Propionate | 12 | $124 | $10 |
| Metformin | 17 | $102 | $6 |
| Rosuvastatin | 11 | $97 | $9 |
| Lisinopril | 18 | $67 | $4 |
| Amlodipine Besylate | 14 | $63 | $5 |
| Prednisone | 11 | $37 | $3 |
2017: 11 drugs
| Lantus Solostar | 11 | $3,420 | $311 |
| Metformin | 99 | $494 | $5 |
| Atorvastatin | 55 | $481 | $9 |
| Lisinopril | 106 | $471 | $4 |
| Pravastatin | 40 | $452 | $11 |
| Hydrochlorothiazide | 71 | $220 | $3 |
| Simvastatin | 44 | $209 | $5 |
| Omeprazole | 23 | $193 | $8 |
| Amlodipine Besylate | 20 | $112 | $6 |
| Glipizide | 36 | $109 | $3 |
| Losartan | 11 | $44 | $4 |
2016: 10 drugs
| Atorvastatin | 38 | $535 | $14 |
| Pravastatin | 32 | $473 | $15 |
| Metformin | 84 | $367 | $4 |
| Lisinopril | 74 | $244 | $3 |
| Simvastatin | 37 | $126 | $3 |
| Omeprazole | 14 | $104 | $7 |
| Hydrochlorothiazide | 30 | $93 | $3 |
| Glyburide | 11 | $78 | $7 |
| Amlodipine Besylate | 19 | $62 | $3 |
| Losartan | 13 | $48 | $4 |
2015: 18 drugs
| Advair Diskus | 18 | $6,273 | $349 |
| Xarelto | 18 | $5,989 | $333 |
| Atorvastatin | 32 | $836 | $26 |
| Bd Ultra-Fine Pen Needle | 12 | $697 | $58 |
| Pravastatin | 26 | $404 | $16 |
| Potassium Chloride | 15 | $386 | $26 |
| Lisinopril | 76 | $270 | $4 |
| Montelukast | 12 | $264 | $22 |
| Amlodipine Besylate | 32 | $185 | $6 |
| Levothyroxine | 12 | $181 | $15 |
| Metformin | 43 | $169 | $4 |
| Pantoprazole | 15 | $163 | $11 |
| Furosemide | 32 | $129 | $4 |
| Omeprazole | 19 | $126 | $7 |
| Hydrochlorothiazide | 26 | $104 | $4 |
| Metoprolol | 13 | $99 | $8 |
| Baclofen | 13 | $81 | $6 |
| Simvastatin | 16 | $65 | $4 |
2014: 7 drugs
| Atorvastatin | 17 | $413 | $24 |
| Lisinopril | 21 | $149 | $7 |
| Amlodipine Besylate | 13 | $117 | $9 |
| Metformin | 16 | $98 | $6 |
| Warfarin | 12 | $76 | $6 |
| Furosemide | 18 | $73 | $4 |
| Propranolol | 12 | $59 | $5 |
2013: 2 drugs
| Propranolol | 11 | $83 | $8 |
| Furosemide | 17 | $62 | $4 |
Money from drug and device companies
$172 in 2025
| 2025 | 5 | 8 | None | $172 |
| 2024 | 2 | 2 | None | $153 |
| 2023 | 2 | 5 | None | $298 |
| 2022 | 2 | 4 | None | $225 |
| 2021 | 1 | 1 | None | $146 |
| 2020 | 1 | 1 | None | $23 |
| 2019 | 2 | 2 | None | $122 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lilly USA | Mounjaro | $48 | 2 payments
|
| Pfizer | Nurtec Odt | $44 | 2 payments
|
| Amgen | Repatha | $38 | 2 payments
|
| Dexcom | Dexcom G6 Transmitter | $21 | 1 payment
|
| Exact Sciences | The Cologuard Plus Collection Kit | $20 | 1 payment
|
See all 8 published payments
| Lilly USA | Meals · 2025-12-17 | None | $34 |
| Exact Sciences | Meals · 2025-11-19 | The Cologuard Plus Collection Kit | $20 |
| Amgen | Meals · 2025-11-11 | Repatha | $22 |
| Lilly USA | Meals · 2025-10-27 | Mounjaro | $14 |
| Dexcom | Meals · 2025-10-08 | Dexcom G6 Transmitter | $21 |
| Pfizer | Meals · 2025-10-03 | Nurtec Odt | $24 |
| Amgen | Meals · 2025-08-29 | Otezla | $17 |
| Pfizer | Meals · 2025-07-18 | Nurtec Odt | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $153
| Biotissue Holdings | None | $135 | 1 payment
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $18 | 1 payment
|
2023: $298
| Biotissue Holdings | Neox | $277 | 4 payments
|
| Abbvie | Vraylar | $21 | 1 payment
|
2022: $225
| Smith+Nephew | Grafix Pl | $163 | 1 payment
|
| Abbvie | Vraylar | $62 | 3 payments
|
2021: $146
| Smith+Nephew | Grafix Pl | $146 | 1 payment
|
2020: $23
| AbbVie | Mavyret | $23 | 1 payment
|
2019: $122
| Smith+Nephew | Grafix Pl Prime | $93 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $29 | 1 payment
|
Professional record
- NPI
- 1043566623
- Licence
- CA A132424California A132424: Current · expires 2027-12-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 18181 Butterfield Blvd Ste 180a, Morgan Hill, CA, 95037
- NPI first listed
- 2012-08-01
- NPI last updated
- 2025-03-03
- NPI record certified
- 2025-03-03
This is when the NPI record was last certified, not a medical board exam.